Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B

T. R. Coven, L. H. Burack, R. Gilleaudeau, M. Keogh, M. Ozawa and J. G. Krueger
Laboratory for Investigative Dermatology, Rockefeller University Hospital, New York, NY. 10021-6399, USA.

OBJECTIVE: To compare the therapeutic effectiveness of daily exposure to narrowband (NB) UV-B vs broadband (BB) UV-B with and without tar. DESIGN: Half-body exposures to NB UV-B or BB UV-B were given daily for 4 weeks in this comparative treatment study. Narrowband UV-B was delivered from TL-01 fluorescent bulbs and BB UV-B from conventional bulbs in the same phototherapy cabinet. Narrowband UV-B was compared using a paired treatment approach to BB UV-B above the waist and to BB UV-B with tar (Goeckerman treatment) below the waist. SETTING: General clinical research center of a university hospital inpatient unit. PATIENTS: Twenty-two patients with moderate-to-severe plaque-type psoriasis completed the study. MAIN OUTCOME MEASURES: Clinical efficacy was measured weekly using psoriasis severity scoring. Therapeutic outcomes after 4 weeks were compared in paired biopsy samples from treated lesions using objective histopathological measures (quantitative reduction in epidermal acanthosis and keratin 16 expression). RESULTS: Clinical resolution of psoriasis was achieved on 86% of paired sites treated with NB UV-B vs 73% treated with BB UV-B. Histopathological resolution of epidermal hyperplasia (marked by keratin 16 expression) was achieved in 88% of lesions treated with NB UV-B vs 59% treated with BB UV-B. Epidermal acanthosis was reduced more completely by NB UV-B treatment. Clinical resolution of psoriatic lesions occurred more rapidly following NB UV-B treatment, with some patients achieving complete resolution after 2 to 3 weeks of treatment. CONCLUSIONS: Narrowband UV-B offers a significant therapeutic advantage over BB UV-B in the treatment of psoriasis, with faster clearing and more complete disease resolution. The erythema response to NB UV-B treatment was significantly more intense and persistent compared with BB UV-B. Considerably more necrotic keratinocytes were observed in histopathological sections of skin treated with NB UV-B after a single 2.0-minimum erythema dose exposure. Treatment should be coupled with obligate minimum erythema dose testing to NB UV-B and close clinical observation during dose increases.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psoriasis treatment: traditional therapy
Lebwohl et al.
Ann Rheum Dis 2005;64:ii83-ii86.
ABSTRACT | FULL TEXT  

Narrowband UV-B (TL-01) Phototherapy vs Oral 8-Methoxypsoralen Psoralen-UV-A for the Treatment of Chronic Plaque Psoriasis
Markham et al.
Arch Dermatol 2003;139:325-328.
ABSTRACT | FULL TEXT  

Narrowband (312-nm) UV-B Suppresses Interferon {gamma} and Interleukin (IL) 12 and Increases IL-4 Transcripts: Differential Regulation of Cytokines at the Single-Cell Level
Walters et al.
Arch Dermatol 2003;139:155-161.
ABSTRACT | FULL TEXT  

Narrowband TL-01 Phototherapy for Patch-Stage Mycosis Fungoides
Clark et al.
Arch Dermatol 2000;136:748-752.
ABSTRACT | FULL TEXT  

Narrowband UV-B Phototherapy vs Photochemotherapy in the Treatment of Chronic Plaque-Type Psoriasis: A Paired Comparison Study
Tanew et al.
Arch Dermatol 1999;135:519-524.
ABSTRACT | FULL TEXT  

The Use of Narrowband UV-B (Tube Lamp) in the Management of Skin Disease
Ferguson
Arch Dermatol 1999;135:589-590.
FULL TEXT  

312-nanometer Ultraviolet B Light (Narrow-Band UVB) Induces Apoptosis of  T Cells within Psoriatic Lesions
Ozawa et al.
J. Exp. Med. 1999;189:711-718.
ABSTRACT | FULL TEXT